Brief: Arix Bioscience Says Positive Clinical Progression In Group Businesses
10/08/2018 07:13
Aug 10 (Reuters) - Arix Bioscience PLC ARIX.L :
* POSITIVE CLINICAL PROGRESSION IN GROUP BUSINESSES
Source text for Eikon: ID:nPRrA7AA1a
Further company coverage: ARIX.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Arix Bioscience
See all newsBrief: Arix Bioscience Says Sale Of Harpoon Is Expected To Deliver Net Proceeds Of About $18.9 Mln
Brief: Arix Bioscience Total NAV Of £228.5 MLN As At 31 October 2023
Brief: RTW Biotech To Acquire Arix Bioscience's Assets
RTW Biotech to acquire Arix Bioscience's assets
Brief: Arix Bioscience Says Board Exploring Range Of Strategic Options For Co